Showing results (171-180 of 220) with videos related to
Sort By:
Pageof 22
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 17, 2023
Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world studyLaura Gutierrez-Sainz, Sara Martinez-Fdez, Jorge Pedregosa-Barbas, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 1, 2024
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysisPablo Cerezuela-Fuentes, Maria Gonzalez-Cao, Teresa Puertolas, et al.Cancers|July 3, 2020
Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with CrossoverCeleste Lebbé, Caroline Dutriaux, Thierry Lesimple, et al.Cancers|January 11, 2022
Prediction of Chemotoxicity, Unplanned Hospitalizations and Early Death in Older Patients with Colorectal Cancer Treated with ChemotherapyJaime Feliu, Enrique Espinosa, Laura Basterretxea, et al.Neoplasia (New York, N.Y.)|January 12, 2013
MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patientsAngelo Gámez-Pozo, Luis M Antón-Aparicio, Cristina Bayona, et al.Scientific Reports|January 21, 2026
Protein content of extracellular vesicles from patients with advanced melanoma changes upon progression to anti-PD1 therapyLucía Trilla-Fuertes, Angelo Gámez-Pozo, Fernando Laso-García, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 15, 2024
Access to melanoma drugs in Spain: a cross-sectional surveyMaria Gonzalez-Cao, Teresa Puertolas, Jose Luis Manzano, et al.Journal of Geriatric Oncology|October 28, 2020
Undertreatment and overtreatment in older patients treated with chemotherapyJaime Feliu, Enrique Espinosa, Laura Basterretxea, et al.Journal of Clinical Medicine|January 8, 2023
Proteomics Characterization of Clear Cell Renal Cell CarcinomaJesús Miranda-Poma, Lucía Trilla-Fuertes, Rocío López-Vacas, et al.Journal for Immunotherapy of Cancer|June 6, 2024
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanomaJoseph J Sacco, Richard D Carvajal, Marcus O Butler, et al.Pageof 22